The global alogliptin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Alogliptin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus, however, it is not used to treat type 1 diabetes. The major factor expected to drive the market […]
